Jeanne Tie Selected Research

Jeanne Tie Research Topics

Disease

40	Neoplasms (Cancer) 03/2024 - 05/2011
37	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 05/2011
12	Colonic Neoplasms (Colon Cancer) 10/2023 - 01/2015
9	Neoplasm Metastasis (Metastasis) 11/2023 - 05/2011
9	Rectal Neoplasms (Rectal Cancer) 01/2023 - 01/2018
7	Residual Neoplasm 01/2023 - 01/2016
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 01/2017
4	Inflammation (Inflammations) 10/2021 - 09/2015
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2024 - 04/2022
2	Aneuploidy (Aneuploid) 01/2024 - 01/2020
2	Hemorrhage 11/2023 - 08/2017
2	Thrombosis (Thrombus) 11/2023 - 08/2017
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 11/2018 - 09/2015
1	Stomach Neoplasms (Stomach Cancer) 03/2024
1	Thromboembolism 11/2023
1	Ovarian Neoplasms (Ovarian Cancer) 10/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2021
1	Fatigue 10/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020
1	Edema (Dropsy) 10/2020
1	Exanthema (Rash) 10/2020
1	Necrosis 10/2020
1	Pseudomyxoma Peritonei 01/2020
1	Microsatellite Instability 01/2020
1	Peritoneal Diseases 08/2019
1	Peritoneal Neoplasms 08/2019
1	Adenocarcinoma 07/2019
1	Appendiceal Neoplasms (Appendix Cancer) 01/2019
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 01/2019
1	Turcot syndrome 11/2018
1	Hepatocellular Carcinoma (Hepatoma) 10/2018
1	Liver Neoplasms (Liver Cancer) 10/2018
1	Stomatitis 01/2017
1	Diarrhea 01/2017
1	Hyperphosphatemia 01/2017
1	Circulating Neoplastic Cells 02/2014

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 03/2024 - 02/2014
17	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2019
15	Circulating Tumor DNAIBA 01/2024 - 02/2014
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2015
4	Cell-Free Nucleic AcidsIBA 01/2024 - 01/2016
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2023 - 01/2015
3	catch-relaxing peptide (Mytilus)IBA 10/2022 - 01/2022
3	Bevacizumab (Avastin)FDA Link 11/2020 - 06/2016
3	Monoclonal AntibodiesIBA 10/2020 - 01/2016
3	LigandsIBA 10/2020 - 12/2019
3	ErbB Receptors (EGF Receptor)IBA 06/2020 - 01/2016
3	Immune Checkpoint InhibitorsIBA 01/2020 - 10/2018
2	Cetuximab (Erbitux)FDA Link 01/2023 - 01/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 01/2020
2	Capecitabine (Xeloda)FDA Link 08/2021 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 08/2021 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2017 - 01/2012
1	Enoxaparin (Lovenox)FDA LinkGeneric 11/2023
1	Fibrinogen (Factor I)FDA Link 11/2023
1	fibrin fragment D (D-dimer)IBA 11/2023
1	AntibodiesIBA 01/2023
1	Gefitinib (Iressa)FDA Link 01/2023
1	VemurafenibIBA 01/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2023
1	sotorasibIBA 01/2022
1	adagrasibIBA 01/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2021
1	Macrophage Colony-Stimulating FactorIBA 10/2020
1	pembrolizumabIBA 10/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2020
1	Nucleic AcidsIBA 10/2020
1	Cytotoxins (Cytolysins)IBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	ElementsIBA 01/2020
1	Epidermal Growth Factor (EGF)IBA 12/2019
1	sodium-iodide symporter (sodium iodide symporter)IBA 01/2018
1	2- (4- (2- (5- (1- (3,5- dichloropyridin- 4- yl)ethoxy)- 1H- indazol- 3yl)vinyl)- 1H- pyrazol- 1- yl)ethanolIBA 01/2017
1	Hematoxylin (Haematoxylon)IBA 02/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2016
1	Codon (Codons)IBA 01/2016
1	Panitumumab (Vectibix)FDA Link 01/2016
1	Mitogen-Activated Protein KinasesIBA 06/2015
1	raf KinasesIBA 03/2015
1	Metformin (Glucophage)FDA LinkGeneric 01/2015
1	Calcibiotic Root Canal SealerIBA 05/2011

Therapy/Procedure

26	Therapeutics 01/2024 - 12/2014
11	Adjuvant Chemotherapy 01/2024 - 02/2016
7	Drug Therapy (Chemotherapy) 12/2023 - 09/2015
7	Neoadjuvant Therapy 01/2023 - 08/2021
7	Hyperthermic Intraperitoneal Chemotherapy 10/2022 - 01/2019
5	Cytoreduction Surgical Procedures 10/2022 - 08/2019
2	Chemoradiotherapy 03/2022 - 11/2021
1	Radiotherapy 03/2022
1	Combination Drug Therapy (Combination Chemotherapy) 03/2022
1	Metastasectomy 01/2021
1	Immunotherapy 11/2018
1	Biological Therapy 06/2016
1	Transplantation 04/2015
1	Radiofrequency Ablation 04/2015